人β神经生长因子在大肠杆菌中的高表达

将编码人β神经生长因子(Huβ-HGF)的基因克隆到由T7噬菌体启动子控制的pET11c大肠杆菌表达载体中,重组质粒经鉴定含有Huβ-NGF基因,未解聚的表达产物经SDS-聚丙烯酰胺凝胶电泳(SDS-PAGE),结果显示出二聚体27kD的蛋白带。而完全解聚的表达产物SDS-PAGE显示出一条13β5kD单体带。经凝胶电泳扫描,表达带占菌体总蛋白的14.5％。用兔抗鼠β—NGF的多克隆抗体进行的Western-Blot的结果表明,二聚体同单体都有免疫原性。在生物活性的鉴定中,菌体表达产物可以使小鸡鸡胚的背根神经节产生神经元突起,由此可以证明该表达产物有较高的生物活性。     

人β神经生长因子基因稀有密码子及mRNA二级结构对其在大肠杆菌中表达的影响

目的:研究人β神经生长因子(β-NGF)基因中稀有密码子及其mRNA二级结构对其在大肠杆菌中表达量的影响。方法:根据对人β-ngf中稀有密码子及其mRNA二级结构的研究,同义突变人β-ngf基因,通过PCR得到人β-ngf的5’端同义突变基因rh-β-ngfp32和全同义突变基因rh-β-ngfmu,将这2个序列克隆入载体pET3a中,得到重组质粒pET3a-ngfp32和pET3a-ngfmu,分别转化大肠杆菌BL21(DE3)感受态,IPTG诱导表达,收集菌体,SDS-PAGE检测其表达量的改变。结果:构建的pET3a-ngfp32和pET3a-ngfmu表达载体酶切和测序结果正确,SDS-PAGE结果显示,与在重组菌pET3a-NGF总蛋白中的表达量相比,目的蛋白rh-β-NGF在重组菌pET3a-NGFP32和pET3a-NGFmu中的表达量均明显增高,并且在重组菌pET3a-NGFmu中的表达量高于重组菌pET3a-NGFP32。结论:目的蛋白rh-β-NGF在重组菌pET3a-NGFP32和pET3a-NGFmu中表达量的增高,说明人β-ngf基因中稀有密码子和mRNA的二级结构对其在大肠杆菌中的表达有较为明显的影响,结果为构建rh-β-NGF的大肠杆菌工程菌株奠定了基础。     

人β神经生长因子在大肠杆菌中的高表达

将编码人β神经生长因子(Huβ-HGF)的基因克隆到由T7噬菌体启动子控制的pET11c大肠杆菌表达载体中,重组质粒经鉴定含有Huβ-NGF基因,未解聚的表达产物经SDS-聚丙烯酰胺凝胶电泳(SDS-PAGE),结果显示出二聚体27kD的蛋白带。而完全解聚的表达产物SDS-PAGE显示出一条13β5kD单体带。经凝胶电泳扫描,表达带占菌体总蛋白的14.5％。用兔抗鼠β—NGF的多克隆抗体进行的Western-Blot的结果表明,二聚体同单体都有免疫原性。在生物活性的鉴定中,菌体表达产物可以使小鸡鸡胚的背根神经节产生神经元突起,由此可以证明该表达产物有较高的生物活性。     

重组人βNGF在大肠杆菌中的可溶表达、纯化及活性鉴定

旨在大肠杆菌中可溶表达重组人神经生长因子(Recombinant humanβnerve growth factor,rhβNGF),并对表达产物进行分离纯化和生物学活性鉴定。成功扩增h NGFβ亚基基因,将其克隆入pMAL-c2X表达载体,构建了hβNGF-MBP的大肠杆菌表达体系并进行诱导表达,表达产物经纯化后以Factor Xa酶切去除麦牙糖结合蛋白(MBP),Western blot鉴定后以TF-1细胞法检测生物学活性。结果显示,pMAL-c2X-hβNGF经酶切和测序证实构建正确,25℃、180 r/min、0.5 mmol/L IPTG诱导下可溶表达hβNGF-MBP融合蛋白。hβNGF-MBP经Factor Xa酶切后可去除MBP标签,SDS-PAGE分析纯化的hβNGF位于13 k D左右,纯度可达95%。Western blot鉴定为hβNGF,结果表明,比活约为1×10~6 U/mg。在大肠杆菌中成功可溶表达hβNGF,并具有较高的生物学活性。     

分选酶A在pET32a(+)原核表达载体中的表达和鉴定

旨在pET32a(+)原核表达载体中表达金黄色葡萄球菌(Staphylococcus aureus)中的转肽酶分选酶(SrtA)并进行鉴定.以含有pET22-srtA质粒为模板,设计并合成引物,PCR扩增得到SrtA△N24和SrtA△N59基因,经过BamH Ⅰ、Xho Ⅰ酶切,克隆入表达载体pET32a(+)中,构建重组载体pET32a-SrtA△N24及pET32a-SrtA△N59,并转化入大肠杆菌BL21(DE3).经异丙基硫代-β-D-半乳糖苷(IPTG)诱导表达后用SDS-PAGE和Western blotting对表达产物分别进行分析和鉴定.然后对重组质粒在大肠杆菌BL21(DE3)中的表达条件进行了优化.结果显示重组载体pET32a-SrtA△N24和pET32a-SrtA△N59分别表达出相对分子量为约42 kD和37 kD的融合蛋白,经SDS-PAGE和Westem blotting检测显示其分子量与预期的大小相符合.成功构建了重组质粒pET32a-SrtA△N24和pET32a-SrtA△N59,并且在大肠杆菌BL21(DE3)中获得了高效融合表达.     

炭疽杆菌噬菌体裂解酶基因在大肠杆菌中的表达及鉴定

利用PCR方法扩增炭疽杆菌噬菌体裂解酶 (γlysin)基因 ,克隆至大肠杆菌表达载体pET2 2b中 ,经菌落PCR筛选、序列测定和酶切鉴定证实表达载体pET22b-γlysin构建成功 ,并在EscherichiacoliBL21(DE3)中获得了高表达。目的蛋白约占菌体总蛋白的40% ,5L发酵罐中的产酶水平高达 15g L。菌体经超声破碎 ,制备无细胞抽提液 ,StreamlineSP和SPHP柱层析以及SephacrylS-100凝胶过滤三步纯化 ,得到分子量为 2 7kD单一条带的目的蛋白 ,薄层扫描分析显示其纯度大于 95 %。目的蛋白的收率为19.1% ,纯化倍数为350。生物活性鉴定重组的γ噬菌体裂解酶具有特异性 :可快速裂解炭疽杆菌 ,比活为 1400u mg左右 ;而对大肠杆菌、枯草杆菌及蜡样芽孢杆菌没有裂解活性。     

重组人神经生长因子rh-β-NGF真核表达载体的构建及其在HEK293细胞中的表达

为大量制备β-NGF,构建了一种稳定、高效表达重组人神经生长因子(Recombinant human nerve growth factor,rh-β-NGF)的真核表达载体及含该重组载体的HEK293细胞株。首先,构建重组质粒p CMV-β-NGF-IRES-dhfr并转染至HEK293细胞系,用MTX加压筛选和有限稀释法进行选择,获得高效表达rh-β-NGF的单克隆重组细胞株;随后逐步降低血清培养,最终使细胞株完全适应无血清培养基并稳定表达rh-β-NGF;SDS-PAGE分析该表达产物,可见相对分子质量约13 k Da的条带,纯度大于50%,经质谱法测定得到其肽图谱与理论序列完全匹配,接着利用离子交换层析和分子筛层析纯化rh-β-NGF;最后进行重组细胞株表达效率和表达稳定性检测,表明重组细胞株可稳定、高效表达rh-β-NGF,其分泌效率大于20 pg/(cell?d),并能诱导PC12细胞的分化,具有良好的生物学活性。     

人钙调素在大肠杆菌中的表达、纯化及其活性研究

利用基因重组技术,将经PCR扩增获得的人钙调素基因(hCaMcDNA)插入质粒pBV220,构建重组表达载体hCaM/pBV220,用酶切、DNA测序、PCR扩增鉴定阳性克隆.阳性重组子在大肠杆菌DH5α中经温度诱导可高效表达CaM蛋白,经15%SDS-PAGE分析,可观察到一与CaM分子量相符(约17kD)的诱导表达条带,其表达量占菌体蛋白总量20%,并主要以可溶性形式表达.Westernblot结果证实,17kD的表达条带可与标准鼠抗人CaM单克隆抗体起特异反应.用Pheny1-SepharoseCL-4B疏水亲和层析法纯化重组菌超声上清表达产物,每1L菌液可获CaM纯品3～4mg.重组人CaM(rhCaM)与牛脑CaM的氨基酸组成基本一致.生物活性测定结果提示,rhCaM具有激活NAD激酶的活性,其激活程度与标准人脑CaM几乎一致.     

弗氏柠檬酸菌甘油脱水酶基因在大肠杆菌中的克隆和表达

以弗氏柠檬酸菌（Citrobacter freundii）基因组DNA为模板,通过PCR得到甘油脱水酶（glycerol dehydratase）基因dhaB、dhaC、dhaE,克隆到表达载体pSE380上,得到重组质粒pSn-dhaBCE。将此重组质粒转化到E．coli JM109中,重组菌株SDS-PAGE结果显示有明显的61kD、22kD、16kD三条特异性蛋白条带出现。重组菌株经诱导表达,酶活力为11．59U／mL。     

凡纳滨对虾β-actin基因的克隆与表达

目的:克隆凡纳滨对虾肌动蛋白基因并在原核表达系统中表达.方法:根据GenBank上凡纳滨对虾β-actin基因序列设计引物,采用RT-PCR方法,从凡纳滨对虾肌肉组织中克隆出β-肌动蛋白基因cDNA部分序列,克隆序列连接到pBAD/gⅢA质粒,转化人大肠杆菌TOP10,筛选阳性克隆,进行温度诱导表达重组蛋白.结果:克隆序列长度为1300bp,测序结果与Gene-Bank序列同源性达99.91%;获得重组体诱导表达产物经SDS-PAGE分析,在约48kD处有表达的蛋白带,表达产物经Western Blotting鉴定为阳性.结论:获得β-actin基因在大肠杆菌中稳定表达产物.     

Optimization of recombinant β-NGF expression in Escherichia coli using response surface methodology

Human nerve growth factor a member of the neurotrophin family can be used to treat neurodegenerative diseases. As it has disulfide bonds in its structure, periplasmic expression of it using appropriate signal sequence is beneficial. Therefore, in this work β-nerve growth factor (β-NGF) was expressed in Escherichia coli using pET39b expression vector containing DsbA signal sequence. In an initial step, the effect of isopropyl β-D-1-thiogalactopyranoside (IPTG) and lactose concentration as inducer on protein production was investigated using response surface methodology. Then the effect of different postinduction time and temperature on protein production was studied. Our results indicated that the highest β-NGF production was achieved with 1?mM IPTG and low concentrations of lactose (0–2% w/v), low cultivation temperature of 25°C and postinduction time of 2?hr. Also following β-NGF purification, bioassay test using PC12 cell line was done. The biological activity of the purified β-NGF showed a similar cell proliferation activity with the standard recombinant human β-NGF. In conclusion, the results indicated an optimized upstream process to obtain high yields of biologically active β-NGF.     

两步柱色谱法纯化 CHO 表达的重组人β神经生长因子（β-rhNGF）

基因重组技术生产蛋白药物较传统提取生产方式具有诸多优点。本文运用一步离子交换色谱层析（Sepharose Fast Flow）和反相(C4)色谱层析串联纯化了CHO 工程细胞株分泌表达的重组人β 神经生长因子（β-rhNGF）,纯化产物经SDS-PAGE及反相HPLC 分析纯度均达到 95% 以上,生物学活性经 PC12 细胞和鸡胚背根神经节测定均与 Sigma 标准品无差异。产物经两步纯化后的收率达70% 以上,为建立该产品切实可行的工业化纯化工艺提供了依据。     

重组人β防御素3在大肠杆菌中的表达和活性分析

防御素是生物界广泛分布的一类低分子短肽,具有广谱高效的杀菌、抗肿瘤作用,并且不易使微生物产生抗药性,具有很高的应用价值,其中最引人注目的是β防御素[1,2].人β防御素3(humanβ-defensin3,hBD3)是最近发现的第3种人源性β防御素,与其它人防御素相比,在抗菌活性等方面具有明显优势,是所有防御素中抗菌能力最强的之一[3~7],具有独特的研究和开发价值.为了得到高效表达hBD3的工程菌株,本实验按照细菌对密码子的偏爱,人工合成了hBD3的寡核苷酸片段,构建了其表达载体.经IPTG诱导、分离纯化和肠激酶切割,得到了与天然hBD3活性基本相同的…     

The unprocessed C-terminal dipeptide of recombinant beta-nerve growth factor determines three stable forms with distinct biological activities.

The processing of polypeptide neurotrophins in the nervous system is poorly understood. In this paper, we provide information on the effects of C-terminal processing of nerve growth factor. Three forms of recombinant mouse beta-nerve growth factor (rNGF) were produced and isolated from insect cells infected with a recombinant baculovirus. The three purified forms of rNGF exhibited distinct biological activities and differed in their abilities to compete with high affinity binding of mouse beta-nerve growth factor (mNGF). However, they were chemically and structurally indistinguishable from each other. All three forms of rNGF differed from mature mNGF from mouse submaxillary gland in that the C-terminal Arg-Gly dipeptide had not been proteolytically removed. Removal of the C-terminal dipeptide by gamma-NGF peptidase treatment converted the three forms into a single form identical with mature mNGF. The above results demonstrate that a single polypeptide of rNGF, due to the presence of a C-terminal dipeptide, exhibits three stable dimeric protein conformations with distinct biological activities. The apparent lack of gamma-NGF peptidase in the nervous system raises the possibility that the biologically significant form of NGF may differ from mature mNGF; such a difference may be of physiological relevance.     

Synthesis of nerve growth factor in rat glioma cells

We have analyzed the incorporation of radioactive amino acids by rat C6 glioma cells into material precipitable with anti-β-nerve growth factor (NGF). We show that amino acids are incorporated into a protein the size of β-NGF which is immunologically related to NGF and which has peptides similar to those of mouse β-NGF. Several lines of evidence obtained in this study support the hypothesis that NGF is produced by the proteolytic cleavage of a higher molecular weight precursor. This evidence includes kinetic studies, demonstration of higher molecular weight material (24,000) immunologically related to NGF, and in vitro processing of the 24,000 MW protein to material of the approximate size of β-NGF.     

Overexpression of β-NGF promotes differentiation of bone marrow mesenchymal stem cells into neurons through regulation of AKT and MAPK pathway

Bone marrow stromal stem cells (BMSCs) are fibroblastic in shape and capable of self-renewal and have the potential for multi-directional differentiation. Nerve growth factor (NGF), a homodimeric polypeptide, plays an important role in the nervous system by supporting the survival and growth of neural cells, regulating cell growth, promoting differentiation into neuron, and neuron migration. Adenoviral vectors are DNA viruses that contain 36 kb of double-stranded DNA allowing for transmission of the genes to the host nucleus but not inserting them into the host chromosome. The present study aimed to investigate the induction efficiency and differentiation of neural cells from BMSCs by β-NGF gene transfection with recombinant adenoviral vector (Ad-β-NGF) in vitro. The results of immunochemical assay confirmed the induced cells as neuron cells. Moreover, flow cytometric analysis, Annexin-V-FITC/PI, and BrdU assay revealed that chemical inducer β-mercaptoethanol (β-met) triggered apoptosis of BMSCs, as evidenced by inhibition of DNA fragmentation, nuclear condensation, translocation of phospholipid phosphatidylserine, and activation of caspase-3. Furthermore, the results of western blotting showed that β-met suppressed AKT signaling pathway and regulated the MAPKs during differentiation of BMSCs. In contrast, Ad-β-NGF effectively induced the differentiation of BMSCs without causing any cytopathic phenomenon and apoptotic cell death. Moreover, Ad-β-NGF recovered the expression level of phosphorylated AKT and MAPKs in cells exposed to chemical reagents. Taken together, these results suggest that β-NGF gene transfection promotes the differentiation of BMSCs into neurons through regulation of AKT and MAPKs signaling pathways.     

Characterization of a β-nerve growth factor expression vector for mammalian cells

A mammalian expression vector that directs expression of murine β-nerve growth factor (β-NGF) from a murine sarcoma virus long terminal repeat (LTR) promoter element was constructed and characterized. The vector, designated pLTRSNGF, was stably transfected into murine L-cells, and β-NGF mRNA and protein levels were quantified and compared to endogenous levels in control L-cells. Transfection of pLTRSNGF resulted in an approximate doubling of both β-NGF mRNA and mature β-NGF protein secreted into the media. Transfection of pLTRSNGF into rat PC 12 cells resulted in colonies of autocrine-differentiating cells that extended dense networks of neurites in the absence of added NGF, indicating that the β-NGF produced from the vector is biologically active.     

Nerve growth factor biosynthesis: Isolation and characterization of a guinea pig prostate kallikrein

Guinea pig prostate contains one major soluble esteropeptidase activity. The protein has been purified and characterized and found to be a glycoprotein comprised of a single polypeptide chain. The molecular weight of the deglycosylated protein is approximately 26,000. The esteropeptidase has a similar K_m for lysine and arginine synthetic substrates, although the V_max for arginine is much greater than that for lysine. Amino-terminal sequence analysis has also revealed a marked degree of homology to mouse γ-nerve growth factor (NGF) and the kallikrein family of serine proteases. In contrast to γ-NGF, however, the guinea pig enzyme does not appear to form stable complexes with β-NGF.     

重组人半乳凝集素-1的原核表达、纯化及生物活性检测

目的:在大肠杆菌中表达半乳凝集素-1(galectin-1),并进行纯化及生物活性检测。方法:将人半乳凝集素-1基因克隆至带有His融合标签的原核表达载体pQE-30上,转化大肠杆菌M15,经IPTG诱导表达,表达产物经亲和层析纯化后,进行Western印迹鉴定,并用红细胞凝集试验检测其生物学活性。结果:双酶切鉴定和核苷酸序列测定表明重组表达质粒pQE-30-Galectin-1构建正确;重组蛋白的表达量约占菌体总蛋白的50%,主要以可溶形式表达,纯化后蛋白纯度达95%以上,且具有良好的红细胞凝集活性。结论:在大肠杆菌中表达了重组人半乳凝集素-1,且具有良好的生物活性。